William E. Rote, Senior Vice President, R&D at Travere Therapeutics, Inc. (TVTX), sold 2,500 shares at $27.35 ($70K) on 2021-02-17, disclosed to the SEC on 2021-02-18.
Scheduled sale ($70k) by Senior Vice President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.35 | 1,250 | $34K | 48.8% |
| 2 | $28.67 | 1,250 | $36K | 51.2% |
| Total | $28.01 avg | 2,500 | $70K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |